Stroke Emerges as a National Healthcare Challenge... JLK Targets Global Leadership with AI Solutions

As the government actively works to strengthen the critical emergency medical system for conditions such as stroke, JLK (CEO Kim Dongmin), a leading medical artificial intelligence (AI) company, drew attention by presenting AI solutions to national challenges at MICCAI 2025, the world’s most prestigious international academic conference.

On October 2, JLK announced that it had showcased the achievements of building a domestic stroke database and proposed innovative improvements to treatment workflows, presenting its vision as a core partner in the future of essential healthcare.

Ryu Wiseon, Chief Medical Officer (CMO) of JLK, delivered a presentation titled “Streamlining Stroke Workflow Using AI and Overcoming Challenges in Government Programs.” He revealed the establishment of the country’s largest brain MRI data center, built with government project support, and the development of AI software based on clinical big data. This aligns precisely with the government’s policy direction to strengthen essential healthcare, suggesting that JLK’s technology could become a core infrastructure for the domestic stroke medical system, beyond simply developing software.

JLK emphasized that its AI solution supports rapid and accurate patient classification and treatment decision-making, helping to bridge the medical gap between metropolitan and non-metropolitan areas and establish a standardized, high-quality stroke care environment nationwide. This was recognized by conference participants as a realistic alternative to the “emergency room revolving door” and other critical emergency care gaps that have recently emerged as major social issues.

JLK is developing an AI software package capable of comprehensive analysis of major stroke conditions such as cerebral infarction, cerebral hemorrhage, and large vessel occlusion, supporting the establishment of patient-tailored treatment strategies in domestic clinical settings. In particular, the efficiency of these workflows has been validated through multi-institutional verification and real-world clinical application, attracting significant attention from the medical community.

This presentation at MICCAI 2025 garnered strong interest from conference attendees, once again confirming the competitiveness of JLK’s technology in the global medical AI market. As a result, prospects for overseas market entry have improved, and opportunities for expanding global partnerships and pioneering new markets are growing.

A company representative stated, “This presentation was an opportunity to showcase internationally that JLK’s unrivaled technology is a core solution for addressing critical disease care gaps and regional healthcare disparities targeted by the government. Stroke is now a challenge that the entire nation must address, not just individual hospitals. We will continue to work closely with the government and the medical community to advance the domestic stroke response system and, based on this, become a leading company in the global market.”

JLK is expanding its business into regions such as Japan and North America, further solidifying its position as a global medical AI company. With this achievement, the company is expected to usher in a new paradigm for stroke treatment not only domestically but also internationally.

This content was produced with the assistance of AI translation services.